>>Euan Thomson is CEO of Accuray Inc., maker of the CyberKnife radiosurgery system. The device, which uses a highly focused beam of X-ray energy to blast tumors in hard-to-reach places, recently won 510(k) clearance from the Food & Drug Administration for its Lung Optimized Treatment. We asked Thomson to characterize 2010 in terms of the economic climate for medical capital equipment and what developing technologies get the juices flowing at Accuray.
I would say that the word “uncertainty” would characterize 2010. For those of us selling medical capital equipment, it was a year when the environment was fast-changing, with many overlapping variables. The entire year was dominated by uncertainty over whether we were exiting the recession and if so, how fast? Assuming the impact of the recession was diminishing, there was further uncertainty over how soon that would impact access to capital and the capital spending plans of hospitals and other customers.